BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles Its 2021 Forecast Biotech Investing
Risankizumab Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease Biotech Investing
Naturally Splendid Announces Meridian 8-Store Chain To Carry NATERA Plant Based Foods Biotech Investing
Viemed Healthcare Announces Recent Publication of Non-invasive Ventilation Study Medical Device Investing
Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy Pharmaceutical Investing
ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology Pharmaceutical Investing
